Skip to main content

Table 1 Characteristics and genotype distributions of reviewed studies on CD14 -260 (-159) C>T and asthma.

From: Association of CD14 -260 (-159) C>Tand asthma: a systematic review and meta-analysis

Study

Country

Study design

Outcome

Cases

Controls

     

Genotypes

 

Genotypes

 
    

N

CC

CT

TT

N

CC

CT

TT

HWE p

European

            

   Bjornvold [24]a

Norway

CC

AA

103

39

49

15

479

161

233

85

-

   de Faria [27]

Brazil

CC

AA

88

27

41

20

202

63

131

8

< 0.01

   Hakonarson [28]a

Iceland

CC

AA

94

31

46

17

94

29

46

19

-

   Heinzmann [29]

Germany

CC

MA

182

51

89

42

261

79

124

58

0.48

   Kedda [11]b, c

Australia

CC

AA, NAA

568

148

284

136

443

124

226

93

0.59

   Koppelman [30]

Netherlands

CC

MA

159

51

76

32

158

31

85

42

0.31

   Kowal [31]

Poland

CC

AA

372

141

152

79

160

42

73

45

0.27

   Lis [32]

Poland

CC

AA

50

20

24

6

73

28

34

11

0.90

   Murk [4]

USA

CC

AA

97

31

55

11

473

137

236

100

0.93

   Sengler [33]

Germany

NCC

MA

84

23

43

18

119

26

72

21

0.02

   Smit [34]

Denmark

NCC

MA

100

34

47

19

88

26

47

15

0.42

   Smit [35]

France

CC

MA

223

49

107

67

554

145

276

133

0.94

   Woo [36]b

USA

CC

AA, NAA

175

46

94

35

61

20

35

6

0.10

Subtotal

   

2295

691

1107

497

3165

911

1618

636

 

East Asian

            

   Chan [20]d

Hong Kong

CC

MA

269

55

134

80

141

26

77

38

0.23

   Chen [25]

China

CC

MA

150

63

62

25

150

40

68

42

0.25

   Cui [26]

China

CC

AA

143

27

67

49

72

10

42

20

0.11

   Hong [37]b

South Korea

CC

AA, NAA

626

113

284

229

153

22

71

60

0.89

   Kuo Chou [38]

Taiwan

CC

MA

116

17

64

35

232

45

118

69

0.67

   Park [39]

South Korea

CC

MA

85

16

39

30

550

90

267

193

0.88

   Wang [23]

Taiwan

CC

MA

447

57

230

160

509

96

236

177

0.27

   Wu [40]

China

CC

MA

252

54

117

81

227

31

121

75

0.10

Subtotal

   

2088

402

997

689

2034

360

1000

674

 

Indian

            

   Sharma [41]

India

CC

AA

187

43

92

52

227

30

112

85

0.47

North African

            

   Lachheb [42]b

Tunisia

CC

AA, NAA

210

46

90

74

224

36

72

116

< 0.01

Total

   

4780

1182

2286

1312

5650

1337

2802

1511

 
  1. The number of successfully genotyped cases and controls may be less than the total number of cases and controls in the study (i.e. SNP call rate < 100%). Genotype frequencies presented as reported, otherwise calculated from reported genotype percent frequencies. Abbreviations: AA, atopic asthma; CC, case-control; HWE, Hardy-Weinberg equilibrium; MA, mixed asthma; N, genotyped sample size; NA, non-asthma; NAA, non-atopic asthma; NANA, non-atopic non-asthma; NCC, nested case-control.
  2. a Genotype frequencies estimated based on allele frequencies assuming HWE among cases and controls.
  3. b Genotype distribution for AA cases shown (genotype distribution for NAA cases not shown).
  4. c Genotype distribution for NA controls shown (genotype distribution for NANA controls not shown).
  5. d Genotype frequency information from this data set for atopic asthma cases and corresponding controls (not shown) abstracted from Leung et al. [21].